Arch Biopartners Inc. ARCH.V Stock
Arch Biopartners Inc. Price Chart
Arch Biopartners Inc. ARCH.V Financial and Trading Overview
| Arch Biopartners Inc. stock price | 2.37 CAD |
| Previous Close | 1.95 CAD |
| Open | 1.97 CAD |
| Bid | 2 CAD x 0 |
| Ask | 2.01 CAD x 0 |
| Day's Range | 1.97 - 2.02 CAD |
| 52 Week Range | 1.82 - 3.85 CAD |
| Volume | 73.5K CAD |
| Avg. Volume | 36.83K CAD |
| Market Cap | 125.2M CAD |
| Beta (5Y Monthly) | 1.101056 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | September 13, 2000 |
| 1y Target Est | N/A |
ARCH.V Valuation Measures
| Enterprise Value | 125.4M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 52.77166 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 52.858 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Arch Biopartners Inc. Stock Price History
| Beta (5Y Monthly) | 1.101056 |
| 52-Week Change | -31.50% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.85 CAD |
| 52 Week Low | 1.82 CAD |
| 50-Day Moving Average | 2.02 CAD |
| 200-Day Moving Average | 2.6 CAD |
ARCH.V Share Statistics
| Avg. Volume (3 month) | 36.83K CAD |
| Avg. Daily Volume (10-Days) | 36.46K CAD |
| Shares Outstanding | 62.6M |
| Float | 48.81M |
| Short Ratio | 0.59 |
| % Held by Insiders | 19.15% |
| % Held by Institutions | 0% |
| Shares Short | 21.71K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.029% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | -162.93% |
| Operating Margin (ttm) | -146.16% |
| Gross Margin | -40.038% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -76.11% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.37M CAD |
| Revenue Per Share (ttm) | 0.04 CAD |
| Quarterly Revenue Growth (yoy) | 125.29% |
| Gross Profit (ttm) | -502879 CAD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -3865629 CAD |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 708.49K CAD |
| Total Cash Per Share (mrq) | 0.01 CAD |
| Total Debt (mrq) | 5.92M CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.542 |
| Book Value Per Share (mrq) | -0.087 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1660971 CAD |
| Levered Free Cash Flow (ttm) | -467076 CAD |
Profile of Arch Biopartners Inc.
| Country | Canada |
| State | ON |
| City | Toronto |
| Address | 27 Street Clair Avenue East |
| ZIP | M4T 2M5 |
| Phone | 647-428-7031 |
| Website | https://www.archbiopartners.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Arch Biopartners Inc., a biotechnology company, engages in the development of technologies for medical or commercial impact. It focuses on developing its lead drug candidate Metablok to treat dipeptidase-1 mediated organ inflammation in the lungs, liver, and kidneys, which results in organ damage or failure, including in the case of sepsis and COVID-19. The company also develops AB569, an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds. In addition, it develops Borg, a peptide-solid surface interface to inhibit biofilm formation and reduce corrosion; and MetaMx, which are synthetic molecules that target brain tumor initiating cells and invasive glioma cells. Arch Biopartners Inc. is based in Toronto, Canada.
Q&A For Arch Biopartners Inc. Stock
What is a current ARCH.V stock price?
Arch Biopartners Inc. ARCH.V stock price today per share is 2.37 CAD.
How to purchase Arch Biopartners Inc. stock?
You can buy ARCH.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Arch Biopartners Inc.?
The stock symbol or ticker of Arch Biopartners Inc. is ARCH.V.
Which industry does the Arch Biopartners Inc. company belong to?
The Arch Biopartners Inc. industry is Biotechnology.
How many shares does Arch Biopartners Inc. have in circulation?
The max supply of Arch Biopartners Inc. shares is 62.76M.
What is Arch Biopartners Inc. Price to Earnings Ratio (PE Ratio)?
Arch Biopartners Inc. PE Ratio is now.
What was Arch Biopartners Inc. earnings per share over the trailing 12 months (TTM)?
Arch Biopartners Inc. EPS is -0.03 CAD over the trailing 12 months.
Which sector does the Arch Biopartners Inc. company belong to?
The Arch Biopartners Inc. sector is Healthcare.